Dr SHANE RETI (National—Whangarei): Thank you, Madam Chair. It's a pleasure to speak at this annual review, and it's particularly useful to be able to look back through the annual reviews and ask the question: what do we know now? Why we can do that is because when the annual review questions went in, which, as I recall, may have been around November last year, we asked a whole sequence of questions around infectious diseases. We asked a whole sequence of questions around meningitis, measles, and influenza. In fact, we asked 19 questions around that, which leads rather nicely into the discussion which we can have today, basing it off what we learnt last year. What did we know last year—were we ready for what we have today? And we can answer that question by some of the information we got back from the annual reviews. In fact, it lets us talk about several parts. It lets us talk about infectious disease supply chain. It lets us talk about infectious disease contact tracing. It lets us talk about general practice robustness, because we asked all of those questions in the annual review, some of which I will read.